Home
News
Create
Screeners
Insights
Natural Biocon
4.
57
+0.21
(+4.82%)
Market Cap
₹- Cr
PE Ratio
-
Industry
Chemicals
Buy
Sell
Company Performance:
1D
+4.82%
1M
-22.67%
6M
-60.23%
1Y
-65.87%
5Y
-70.72%
View Company Insights
Latest news about Natural Biocon
Natural Biocon Reports Zero Revenue and Rs 4.37 Lakh Loss in Q2 FY2026
Nov 19, 2025
Natural Biocon Limited reported zero net sales for Q2 FY2026, down from Rs 473.69 lakhs in Q2 FY2025. The company posted a net loss of Rs 4.37 lakhs, compared to a profit of Rs 20.24 lakhs in the same quarter last year. For H1 FY2026, profit decreased to Rs 9.49 lakhs from Rs 29.99 lakhs, while revenue fell to Rs 166.57 lakhs from Rs 572.34 lakhs in H1 FY2025. The complete absence of revenue in Q2 raises concerns about the company's operational status and financial health.
Biocon Secures Approval for Generic Liraglutide in India, Expanding Diabetes Treatment Options
Jun 03, 2025
Biocon Surpasses Expectations with Strong Q4 Results, Eyes API Business Recovery
May 09, 2025
Biocon Biologics Advances in European Market with Positive CHMP Opinions for Biosimilar Denosumab
Apr 28, 2025
Biocon Unveils Ambitious 45 Billion Rupee Fundraising Plan Amid Financial Growth
Apr 24, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation